Big Pharma

What Price Life? The Dilemma of Drug Costing

Sue Dewey | Posted 18.08.2014 | UK
Sue Dewey

Listening to the news about NICE turning down yet another cancer drug has made me very sad and a little puzzled. In the space of 10 days two new drugs - Kadcyla and Abiraterone, that would give valuable extra time to breast and prostate cancer sufferers respectively, have been refused because of cost.

Is Our Failure to Invest in an Ebola Cure 'Morally Bankrupt' or Financially Prudent?

Natalie Nezhati | Posted 19.08.2014 | UK
Natalie Nezhati

It could be said that the investment of resources into a cure that could carry a price-tag of £1m plus per person to turn a profit is, in purely financial terms, a ridiculous thing to do. With many pharmaceutical companies linking their moral accountability solely with their shareholders, for those who contract unprofitable, neglected diseases it's often a case of "bad luck" and in many cases "goodbye".

Skeletons in the Cupboard: Open the Door on Hidden Clinical Trials

Michelle Beckett | Posted 18.07.2014 | UK
Michelle Beckett

Last year I put my house on the market. Mostly, I'm too busy to notice the clutter and untidiness that accompanies the life of a lone mum working full time, but I guessed the prospective viewers might...

UK plc Should Not Be the Victim of Big Pharma's Innovation Crisis

Ann McKechin | Posted 14.07.2014 | UK Politics
Ann McKechin

UK plc should not pay for Pfizer's crisis of innovation. AstraZeneca is a strategically important company to the UK, developing vital drugs both here and around the world. A takeover driven by tax efficiency and cash dividend rather than research and innovation imperils the future of UK science, research jobs, and exports.

Osborne Will Get 'Hard-Nosed' With Pfizer

The Huffington Post UK/PA | Posted 10.05.2014 | UK Politics

The boss of US drug giant Pfizer has said the firm's proposed takeover of British-based AstraZeneca is a "win-win for society". Pfizer chairman and...

Brussels-Obsessed? You'd Better Worry About the Encroachment of US 'Big Pharma'

Bonnie Greer | Posted 28.06.2014 | UK
Bonnie Greer

Of course the NHS needs reform. Corruption, where it appears, must be rooted out. No one argues against that. And no, I don't have any answers. But I know is this: we must protect what's left of the NHS. Protect it against the encroachment of hedge funds; cease selling our medical data to private companies so that they can make products to sell back to us.

Big Pharma Harms Patients for Profit but Doctors Must Also Share the Blame

Dr Aseem Malhotra | Posted 14.05.2013 | UK
Dr Aseem Malhotra

I believe I speak for the overwhelming majority of doctors in the NHS when I say I went into medicine to practice evidence based, not corporate-influenced medicine.

Are Scientists Stealing Foreplay?

Kate L. Gould | Posted 20.01.2013 | UK Lifestyle
Kate L. Gould

Once upon a time there was a thing called foreplay. Sometimes it was silent: just a kiss in a club and an awkward scuffle in the toilets. Others took more time with it. They wrote sweet lines, sent flowers, asked a lady to dance and, even, for her hand in marriage before they even embarked on it.

A Fat Woman and a Thin Woman: Which One Is a Burden on the NHS?

Sue Thomason | Posted 14.04.2012 | UK Lifestyle
Sue Thomason

Millions of Sandras and Paulines exist. They show that obesity related illnesses are not related to obesity at all but to lifestyle and more specifically to pressure to be thin and dieting! So why is our Government advising us that obesity causes disease and advising weight loss and dieting, the real causes of these diseases?

What Uniting to Combat Tropical Diseases Will Really Require

Dr Unni Karunakara | Posted 31.03.2012 | UK
Dr Unni Karunakara

Performing a spinal tap under field conditions is nerve-wracking. Sticking a needle into someone's spine to extract spinal fluid is painful and risky and that's just the doctor's perspective. But it's also something that our doctors have to do every day as part of routine tests for advanced stage sleeping sickness.

Do Drug-Free Options Offer Fresh Hope?

Tony Lobl | Posted 10.03.2012 | UK Lifestyle
Tony Lobl

A "drug-free therapy" helps slow the expected decline of people diagnosed with dementia, a study has found. The therapy enabled sufferers to maintai...